Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Neurotech International Ltd runs a Biotechnology Research operation from Nedlands. It is publicly held, and its site is neurotechinternational.com. It holds two addresses on record across two office countries. Headcount on record is 9. Its work is tagged product development, medical research and clinical research. One Australian registration (ABN) is a confirmed match. The record links five similar brands, most of them in Biotechnology Research.
neurotechinternational.com LinkedIn
ABN73610205402
| NEUROTECH INTERNATIONAL LIMITED | ABN 73610205402 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders.
Neurotech has completed a Phase I/II clinical trial in Autism Spectrum Disorder (ASD), which demonstrated safety and efficacy results at 28 days, 20 weeks and 32 weeks of daily treatment with NTI164. The Company commenced a Phase II/III randomised, double-blind, placebo-controlled clinical trial in ASD in Q4 CY2022.
The Company will also be conducting additional Phase I/II trial in Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS), collectively PANDAS/PANS, along with a Phase I/II trial in Cerebral Palsy during CY2023.
Additionally, Neurotech is commercialising Mente, the world’s first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity.
For more information about Neurotech please visit http://www.neurotechinternational.com
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU MT
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Western Australia entity on the ABR: NEUROTECH INTERNATIONAL LIMITED (ABN 73 610 205 402), high confidence.
9 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Two addresses on record across 2 countries. Primary: 145 Stirling Highway, Suite 5 CPC, Nedlands, WA 6009.
None linked to this brand.
Nine tags on the brand's own list, among them product development, medical research and clinical research.
6 profiles list Neurotech International Ltd as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. Invex Therapeutics and 6PR Perth list it back.